March 7, 2018
RunawayRx's Dose of Reality series helps keep the public up-to-date on pharma's latest drug pricing schemes and major happenings around the industry. Our most recent edition highlights the heavy burden of high-priced drugs on everyday Americans, RunawayRx's recent event at the Capitol for American Heart Month, a misleading generic and Oregon's successful drug price transparency legislation.
The New York Times in collaboration with ProPublica published a collection of stories highlighting the burden of high-priced drugs on everyday families. As drugmakers continue to raise prices on life-saving medications, millions of Americans are forced to pay thousands just to survive. Abigail Bostwick was diagnosed with M.S. in 2013 and has since drained her savings and sold personal belongings to help cover the cost of her medications. The price of Ms. Bostwick's indispensable medication: $92,000 a year. 

" I didn't cry when I was handed the diagnosis of M.S.," Ms. Bostwick said. But after learning how much prescriptions would cost, "That was when I felt truly helpless.

"...This is such a huge bill and it's not really something that we can forgo," she said. "We're your basic middle-class couple. We don't have an extravagant lifestyle or anything like that. But we always seem to fall through the cracks."

Read the full New York Times story  here.
In Case You Missed It: Giant Heart Comes to Capitol Steps to Urge Awareness of High-Priced Drug Problem

"Heart disease is the leading cause of death in the United States, making innovation and access to life-saving heart treatments a crucial-priority. But we simply cannot afford to accept endless drug price hikes," said Charles Bacchi, President & CEO of the California Association of Health Plans. "Today's appearance of the giant heart brought us a reminder that skyrocketing drug prices are driving up health care costs and threatening access to life-saving drugs for the very people who need them most. "

Read more here
The New York Times: Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. 

" Teva's new generic will cost $18,375 for a bottle of 100 pills, according to Elsevier's Gold Standard Drug Database. That's 28 times what Syprine cost in 2010, hardly the discount many patients were waiting for.

"...the story of Syprine highlights just how hard it can be to bring down drug prices once they've been set at stratospheric levels ."

Read more here.
The Portland Business Journal: Drug price transparency bill passes Oregon Senate, heads to governor

"House Bill 4005, which passed on a vote of 25-4, requires drug manufacturers to justify price hikes for more expensive prescription drugs . Supporters hope that exposing key cost drivers will spark further strategies to tackle price escalation.

"The bill requires drug manufacturers to report marketing and research costs to the Department of Consumer and Business Services for drugs with a base price of more than $100 and that go up by at least 10 percent in one year. Companies could face civil penalties if they fail to comply." 

Read more here.
For the latest updates and information on the prescription drug pricing crisis, visit the RunawayRx website:
RunawayRx | (818) 760-2121 |